$CERS...It is jumping this morning as the FDA accepts the IDE for INTERCEPT www.cerus.com/Investors/Press-Releases/Press-Release-Details/2014/FDA-Accepts-IDE-Supplement-for-INTERCEPT-Blood-System-Treatment-of-Ebola-Convalescent-Plasma/default.aspx FDA ACCEPTS IDE SUPPLEMENT FOR INTERCEPT BLOOD SYSTEM TREATMENT OF EBOLA CONVALESCENT PLASMA